About
Liver Evaluation Tool
Areas of Focus
Categories
DiagnosticsSoutheastern U.S.
Team (12)
Brock Smith
Chief Executive Officer
Fibronostics
executive
Cassie Davies
Chief Financial Officer
Fibronostics
executive
Dr Mona Munteanu
Chief Scientific Officer MD, PhD
Fibronostics
executive
Dr Ronald Quiambao
Chief Medical Officer MD
Fibronostics
executive
Dr. Meena Bansal
Fibronostics
team_member
Dr. Naim Alkhouri
Fibronostics
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
389
By Phase
NA: 2
By Status
NOT_YET_RECRUITING: 1COMPLETED: 1WITHDRAWN: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06797596Lead Sponsor
Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.
N/ANot yet recruiting
100 participants
Started: May 31, 2025 · Completed: Aug 30, 2025
NCT04579874Lead Sponsor
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
NACompleted
241 participants
Started: Jan 7, 2021 · Completed: Apr 15, 2022
NCT03980912Lead Sponsor
Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
N/AWithdrawn
Started: Sep 1, 2019 · Completed: Nov 1, 2020
NCT04074889Collaborator
The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver
NAUnknown
48 participants
Started: Aug 30, 2019 · Completed: Dec 31, 2020
Locations (1)
Headquarters
Indian Harbour Beach, FL, United States
Map
Loading map...